|
1
|
Fang W and Ruan W: Advances in surgical
treatment of early stage non-small cell lung cancer. Asian Pac J
Surg Oncol. 2:1–10. 2017.
|
|
2
|
Lee PN, Forey BA and Coombs KJ: Systematic
review with meta-analysis of the epidemiological evidence in the
1900s relating smoking to lung cancer. BMC Cancer. 12:3852012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leidinger P, Galata V, Backes C, Stähler
C, Rheinheimer S, Huwer H, Meese E and Keller A: Longitudinal study
on circulating miRNAs in patients after lung cancer resection.
Oncotarget. 6:16674–16685. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Del Vescovo V, Grasso M, Barbareschi M and
Denti MA: MicroRNAs as lung cancer biomarkers. World J Clin Oncol.
5:604–620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tai HC, Chang AC, Yu HJ, Huang CY, Tsai
YC, Lai YW, Sun HL, Tang CH and Wang SW: Osteoblast-derived
WNT-induced secreted protein 1 increases VCAM-1 expression and
enhances prostate cancer metastasis by down-regulating miR-126.
Oncotarget. 5:7589–7598. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H,
Liu X, Le H and Zhang Y: Diagnostic value of serum miR-182,
miR-183, miR-210, and miR-126 levels in patients with early-stage
non-small cell lung cancer. PLoS One. 11:e01530462016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun CC, Li SJ, Zhang F, Zhang YD, Zuo ZY,
Xi YY, Wang L and Li DJ: The novel miR-9600 suppresses tumor
progression and promotes paclitaxel sensitivity in non-small-cell
lung cancer through altering STAT3 expression. Mol Ther Nucleic
Acids. 5:e3872016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu F, Dai C, Fu Y, Loo JF, Xia D, Gao SP,
Ma Z and Chen Z: Physalin A exerts anti-tumor activity in non-small
cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Oncotarget. 7:9462–9476. 2016.PubMed/NCBI
|
|
9
|
Hou J, Meng F, Chan LW, Cho WC and Wong
SC: Circulating plasma MicroRNAs as diagnostic markers for NSCLC.
Front Genet. 7:1932016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu Z, Willmarth NE, Zhou J, Katiyar S,
Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP and Pestell RG:
microRNA 17/20 inhibits cellular invasion and tumor metastasis in
breast cancer by heterotypic signaling. Proc Natl Acad Sci USA.
107:8231–8236. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gong J, Zheng S, Zhang L, Wang Y and Meng
J: Induction of K562 cell apoptosis by As4S4 via down-regulating
miR181. Med Sci Monit. 23:144–150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang J, Lan H, Huang X, Liu B and Tong Y:
MicroRNA-126 inhibits tumor cell growth and its expression level
correlates with poor survival in non-small cell lung cancer
patients. PLoS One. 7:e429782012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fish JE, Santoro MM, Morton SU, Yu S, Yeh
RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY and Srivastava D:
miR-126 regulates angiogenic signaling and vascular integrity. Dev
Cell. 15:272–284. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Z, Lu J, Sun M, Mi S, Zhang H, Luo RT,
Chen P, Wang Y, Yan M, Qian Z, et al: Distinct microRNA expression
profiles in acute myeloid leukemia with common translocations. Proc
Natl Acad Sci USA. 105:15535–15540. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yin Z, Zhang Y, Li Y, Lv T, Liu J and Wang
X: Prognostic significance of STAT3 expression and its correlation
with chemoresistance of non-small cell lung cancer cells. Acta
Histochem. 114:151–158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu Y, Shi Y, Yuan Q, Liu X, Yan B, Chen L,
Tao Y and Cao Y: Epstein-Barr virus encoded LMP1 regulates cyclin
D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells. J Exp
Clin Cancer Res. 32:902013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang J, Guo F, Du Y, Liu X, Qin Q, Liu X,
Yin T, Jiang L and Wang Y: Continuous exposure of non-small cell
lung cancer cells with wild-type EGFR to an inhibitor of EGFR
tyrosine kinase induces chemoresistance by activating STAT3. Int J
Oncol. 46:2083–2095. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jaganathan S, Yue P, Paladino DC,
Bogdanovic J, Huo Q and Turkson J: A functional nuclear epidermal
growth factor receptor, SRC and Stat3 heteromeric complex in
pancreatic cancer cells. PLoS One. 6:e196052011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lo HW, Cao X, Zhu H and Ali-Osman F:
Cyclooxygenase-2 is a novel transcriptional target of the nuclear
EGFR-STAT3 and EGFRvIII-STAT3 signaling axes. Mol Cancer Res.
8:232–245. 2010. View Article : Google Scholar : PubMed/NCBI
|
